GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Bodisen Biotech Inc (LSE:BODI) » Definitions » Cyclically Adjusted Revenue per Share

Bodisen Biotech (LSE:BODI) Cyclically Adjusted Revenue per Share : £0.00 (As of Jun. 2013)


View and export this data going back to . Start your Free Trial

What is Bodisen Biotech Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bodisen Biotech's adjusted revenue per share for the three months ended in Jun. 2013 was £0.020. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is £0.00 for the trailing ten years ended in Jun. 2013.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-05-24), Bodisen Biotech's current stock price is £0.06. Bodisen Biotech's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2013 was £0.00. Bodisen Biotech's Cyclically Adjusted PS Ratio of today is .


Bodisen Biotech Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bodisen Biotech's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bodisen Biotech Cyclically Adjusted Revenue per Share Chart

Bodisen Biotech Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bodisen Biotech Quarterly Data
Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Jun13
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Bodisen Biotech's Cyclically Adjusted Revenue per Share

For the Agricultural Inputs subindustry, Bodisen Biotech's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bodisen Biotech's Cyclically Adjusted PS Ratio Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Bodisen Biotech's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bodisen Biotech's Cyclically Adjusted PS Ratio falls into.



Bodisen Biotech Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bodisen Biotech's adjusted Revenue per Share data for the three months ended in Jun. 2013 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2013 (Change)*Current CPI (Jun. 2013)
=0.02/95.9841*95.9841
=0.020

Current CPI (Jun. 2013) = 95.9841.

Bodisen Biotech Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200306 0.164 70.039 0.225
200309 0.171 71.018 0.231
200312 -0.716 72.808 -0.944
200403 0.078 73.682 0.102
200406 0.151 73.459 0.197
200409 0.197 74.637 0.253
200412 0.148 74.488 0.191
200503 0.159 75.597 0.202
200506 0.295 74.618 0.379
200509 0.373 75.290 0.476
200512 0.266 75.666 0.337
200603 0.347 76.340 0.436
200606 0.485 76.034 0.612
200609 0.369 76.413 0.464
200612 0.111 77.793 0.137
200703 0.141 78.884 0.172
200706 0.087 79.357 0.105
200709 0.063 81.276 0.074
200712 0.044 82.911 0.051
200803 0.025 85.485 0.028
200806 0.032 85.058 0.036
200809 0.051 85.057 0.058
200812 0.136 83.956 0.155
200903 0.058 84.457 0.066
200906 0.035 83.615 0.040
200909 0.015 84.369 0.017
200912 0.042 85.386 0.047
201003 0.037 86.316 0.041
201006 0.105 85.886 0.117
201009 0.076 87.267 0.084
201012 0.031 89.289 0.033
201103 0.029 91.154 0.031
201106 0.041 91.612 0.043
201109 0.052 92.711 0.054
201112 0.103 92.885 0.106
201203 0.032 94.367 0.033
201206 0.043 93.495 0.044
201209 0.096 94.482 0.098
201212 0.064 95.237 0.065
201306 0.020 95.984 0.020

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bodisen Biotech  (LSE:BODI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bodisen Biotech Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bodisen Biotech's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bodisen Biotech (LSE:BODI) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Bodisen Biotech Inc develops, manufactures and sells organic fertilizers, liquid fertilizers, pesticides and insecticides in China.